Shares of hospital operator Tenet Healthcare (NYSE:THC) jumped 12.2% in the afternoon session after the company reported first-quarter 2025 results, which blew past analysts' EPS expectations on a solid revenue beat. Even though total revenue dipped a bit, that was mostly from selling off some hospitals. Looking ahead, Tenet raised its full-year adjusted EPS guidance, while keeping its revenue outlook unchanged, signaling confidence in margin expansion even without top-line acceleration. Overall, this quarter was still solid.
Is now the time to buy Tenet Healthcare? Access our full analysis report here, it’s free.
Tenet Healthcare’s shares are somewhat volatile and have had 13 moves greater than 5% over the last year. But moves this big are rare even for Tenet Healthcare and indicate this news significantly impacted the market’s perception of the business.
Tenet Healthcare is up 11.8% since the beginning of the year, but at $139.96 per share, it is still trading 16.9% below its 52-week high of $168.52 from November 2024. Investors who bought $1,000 worth of Tenet Healthcare’s shares 5 years ago would now be looking at an investment worth $6,827.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。